Latest Insider Transactions at Bicycle Therapeutics PLC (BCYC)
This section provides a real-time view of insider transactions for Bicycle Therapeutics PLC (BCYC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BICYCLE THERAPEUTICS plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BICYCLE THERAPEUTICS plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Pierre Legault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,537
+50.0%
|
$356,296
$8.44 P/Share
|
|
Dec 20
2021
|
Pierre Legault Director |
SELL
Open market or private sale
|
Direct |
7,603
-100.0%
|
$433,371
$57.02 P/Share
|
|
Dec 20
2021
|
Pierre Legault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,603
+50.0%
|
$60,824
$8.41 P/Share
|
|
Oct 18
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
49
-0.02%
|
$2,940
$60.0 P/Share
|
|
Oct 15
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
320
-0.14%
|
$19,200
$60.05 P/Share
|
|
Oct 14
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,631
-2.01%
|
$277,860
$60.0 P/Share
|
|
Oct 11
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-1.07%
|
$270,000
$54.22 P/Share
|
|
Oct 05
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,178
-100.0%
|
$98,010
$45.1 P/Share
|
|
Oct 01
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,188
-35.29%
|
$53,460
$45.0 P/Share
|
|
Sep 23
2021
|
Dominic Smethurst Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$108,000
$18.55 P/Share
|
|
Sep 16
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,955
-36.74%
|
$87,975
$45.01 P/Share
|
|
Sep 15
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-36.05%
|
$135,000
$45.0 P/Share
|
|
Sep 02
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-54.58%
|
$400,000
$40.0 P/Share
|
|
Sep 02
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$400,000
$40.0 P/Share
|
|
Sep 02
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$90,000
$9.82 P/Share
|
|
Sep 02
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-2.08%
|
$200,000
$40.0 P/Share
|
|
Sep 01
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
27,085
-3.47%
|
$1,002,145
$37.33 P/Share
|
|
Sep 01
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,890
+7.89%
|
$320,460
$14.0 P/Share
|
|
Aug 31
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
11,225
-2.21%
|
$404,100
$36.66 P/Share
|
|
Aug 31
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,420
+3.92%
|
$145,880
$14.0 P/Share
|
|
Aug 27
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,808
-0.73%
|
$65,088
$36.02 P/Share
|
|
Aug 27
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,808
+0.73%
|
$25,312
$14.0 P/Share
|
|
Aug 27
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
7,950
-100.0%
|
$278,250
$35.15 P/Share
|
|
Aug 27
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,950
+50.0%
|
$63,600
$8.73 P/Share
|
|
Aug 26
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
550
-100.0%
|
$19,250
$35.04 P/Share
|
|
Aug 26
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
550
+50.0%
|
$4,400
$8.76 P/Share
|
|
Aug 23
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$247,500
$33.02 P/Share
|
|
Aug 23
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$7,500
$1.6 P/Share
|
|
Jul 29
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
12,500
-87.8%
|
$400,000
$32.06 P/Share
|
|
Jul 29
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$12,500
$1.63 P/Share
|
|
Jul 26
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$3,600
$36.0 P/Share
|
|
Jul 26
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.04%
|
$1,400
$14.0 P/Share
|
|
Jul 23
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,782
-1.91%
|
$172,152
$36.02 P/Share
|
|
Jul 23
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,782
+1.88%
|
$66,948
$14.0 P/Share
|
|
Jul 16
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
609
-0.25%
|
$20,706
$34.0 P/Share
|
|
Jul 16
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+0.25%
|
$8,526
$14.0 P/Share
|
|
Jul 15
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
21,970
-8.23%
|
$746,980
$34.28 P/Share
|
|
Jul 15
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,970
+7.6%
|
$307,580
$14.0 P/Share
|
|
Jul 14
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-35.31%
|
$350,000
$35.0 P/Share
|
|
Jul 14
2021
|
Kate Bingham Director |
SELL
Open market or private sale
|
Indirect |
44,295
-2.31%
|
$1,506,030
$34.01 P/Share
|
|
Jul 14
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
14,465
-1.41%
|
$491,810
$34.21 P/Share
|
|
Jul 14
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,331
+3.11%
|
$116,634
$14.0 P/Share
|
|
Jul 13
2021
|
Kate Bingham Director |
SELL
Open market or private sale
|
Indirect |
600
-0.03%
|
$19,800
$33.5 P/Share
|
|
Jul 13
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
38,961
-4.67%
|
$1,285,713
$33.17 P/Share
|
|
Jul 13
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
35,446
+10.89%
|
$496,244
$14.0 P/Share
|
|
Jul 13
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
72,701
-97.85%
|
$2,326,432
$32.75 P/Share
|
|
Jul 13
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
72,701
+29.86%
|
$872,412
$12.28 P/Share
|
|
Jul 12
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,936
-0.75%
|
$61,952
$32.04 P/Share
|
|
Jul 12
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,936
+0.75%
|
$27,104
$14.0 P/Share
|
|
Jul 12
2021
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,028
-100.0%
|
$224,896
$32.03 P/Share
|